Biohaven Pharmaceutical Holding Co Ltd.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

63,992

Value ($000)

9,674

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	9,674	0.0%	63,992	9/30/2022
2022 Q2	8/12/2022	49,354	0.0%	338,714	6/30/2022
2022 Q1	5/16/2022	7,187	0.0%	60,616	3/31/2022
2021 Q4	2/14/2022	7,769	0.0%	56,377	12/31/2021
2021 Q3	11/15/2021	7,629	0.0%	54,917	9/30/2021
2021 Q2	8/16/2021	5,277	0.0%	54,354	6/30/2021
2021 Q1	5/14/2021	3,562	0.0%	52,103	3/31/2021
2020 Q4	3/1/2021	4,250	0.0%	49,585	12/31/2020
2020 Q3	11/13/2020	2,923	0.0%	44,958	9/30/2020
2020 Q2	8/14/2020	3,266	0.0%	44,675	6/30/2020
2020 Q1	5/15/2020	1,740	0.0%	51,120	3/31/2020
2019 Q4	2/14/2020	2,907	0.0%	53,405	12/31/2019